Sleep disturbances in craniopharyngioma: a systematic review and meta-analysis [0.03%]
颅咽管瘤睡眠障碍的系统评价和meta分析研究
Qiang Liang,Tong Yang,Tianyi Hu et al.
Qiang Liang et al.
Background: Craniopharyngioma is a rare, parasellar tumor of low histological malignancy (WHO grade 1) arising from remnants of the Rathke pouch, which can disrupt hypothalamic modulation. Sleep disturbances, including ex...
Meta-Analysis
Pituitary. 2025 Dec 1;29(1):4. DOI:10.1007/s11102-025-01611-3 2025
Patient perceptions of pituitary incidentaloma diagnosis and follow-up: a Pituitary Society international patient survey [0.03%]
垂体偶发瘤的诊断和随访患者的感知：垂体学会国际患者调查
Hidenori Fukuoka,Andrea Glezer,Niki Karavitaki et al.
Hidenori Fukuoka et al.
Purpose: Detection of pituitary incidentalomas is increasing in frequency with the use of advanced imaging techniques. As an adjunct to publication of consensus guidelines on management of pituitary incidentalomas, the Pi...
Defining normative cortisol responses to the insulin tolerance test: A comparison of Elecsys®Cort I and II assays [0.03%]
定义胰岛素耐受性试验的皮质醇正常反应：Elecsys®Cort I和II检测对比分析
Sema Okutan,Stina Willemoes Borresen,Linda Hilsted et al.
Sema Okutan et al.
Background and aim: Monoclonal immunoassays offer greater specificity than polyclonal assays for cortisol measurement, necessitating assay-specific cut-off limits, which have not yet been defined for the insulin tolerance...
Comparative Study
Pituitary. 2025 Dec 1;29(1):3. DOI:10.1007/s11102-025-01608-y 2025
Pituitary tuberculosis in the pediatric population: a systematic review and case report [0.03%]
儿童垂体结核的系统评价和病例报告
Agata Gierlotka,Ryszard Sordyl,Ireneusz Bielecki et al.
Agata Gierlotka et al.
Purpose: This review aims to identify and evaluate the management options for pituitary tuberculosis in the pediatric population. Methods: ...
Loss of heterozygosity and absence of MAX immunostaining in a prolactinoma associated with multiple endocrine neoplasia type 5 (MEN5) [0.03%]
杂合性丢失和MAX染色缺失在与多发内分泌腺瘤病5型(MEN5)相关的泌乳素瘤中的作用
Brigitte Delemer,Simona M Florea,Benedicte Decoudier et al.
Brigitte Delemer et al.
Background: Multiple endocrine neoplasia type 5 (MEN5) is an emerging syndrome caused by germline pathogenic variants involving the MYC Associated Factor X (MAX) gene. Affected individuals typically have pheochromocytomas...
Case Reports
Pituitary. 2025 Nov 12;28(6):127. DOI:10.1007/s11102-025-01607-z 2025
Radiolabeling molecular biomarkers of invasive pituitary adenomas: a narrative review [0.03%]
放射性标记侵袭性垂体腺瘤分子生物标志物：综述式研究
Charbel Marche,Julia C M Knop,Shivashankar Khanapur et al.
Charbel Marche et al.
Purpose: Pituitary adenoma, are common intracranial neoplasms that can exhibit invasive behavior, leading to increased morbidity, recurrence, and resistance to treatment. Identifying biomarkers associated with tumor invas...
Hermann L Müller
Hermann L Müller
Following the diagnosis of craniopharyngioma, patients frequently experience rapid and excessive weight gain resulting in morbid hypothalamic obesity. This condition is commonly attributed to damage to hypothalamic structures caused either ...
Sabrina Chiloiro,Chiara Palumbo,Antonella Giampietro et al.
Sabrina Chiloiro et al.
Acromegaly is a rare disease caused by the elevated and autonomous secretion of growth hormone (GH) from a pituitary somatotroph tumor or neuroendocrine tumors, and the subsequent hypersecretion of insulin-like growth factor I (IGF-I) in pe...
Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas? [0.03%]
生长激素瘤中 somatostatin 5 型受体的表达：Pasireotide 在泌乳素瘤治疗中有何作用？
Nidhi Agrawal,Sonal Mehta,Richard A Feelders et al.
Nidhi Agrawal et al.
The majority of prolactinomas are treated with dopamine agonists (DA) with excellent response, however DA-resistance occurs in 10% of prolactinomas. Somatostatin (SST) receptors have been increasingly studied in prolactinomas. There are fiv...
Endoscopic endonasal resection of giant pituitary adenomas - case series from the referral pituitary center [0.03%]
内镜下经鼻巨大垂体腺瘤切除术——一个转诊中心的病例系列报告
Jacek Kunicki,Barbara Buchalska,Maria Maksymowicz et al.
Jacek Kunicki et al.
Purpose: The giant pituitary adenomas (GPAs) are still a challenging surgical problem. They comprise 10-15% of operated pituitary adenomas. The advances of endoscopic techniques allow the resection of pituitary tumors pre...